2 recruiting, 1 completed, 1 not yet recruiting. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 2, Completed 1, Not yet recruiting 1 |
| Phase 1 | 2 | Recruiting 2 |
Follow Recurrent Adenoid Cystic Carcinoma: new trials by email Literature Review of Recurrent Adenoid Cystic Carcinoma trials Research Report on Recurrent Adenoid Cystic Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP) Sacituzumab Tirumotecan - Recurrent Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma Metastatic | Phase 2 | Not yet recruiting | National Cancer Centre, Singapore | 68 | 2026-11-01 | 2026-07-15 |
| Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma REM-422 - Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma | Phase 1 / Phase 2 | Recruiting | Remix Therapeutics | 125 | 2023-12-20 | 2026-06-24 |
| CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC CB-103, Abemaciclib, Lenvatinib - Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma | Phase 1 / Phase 2 | Recruiting | Michael J. Dennis, MD | 32 | 2023-06-01 | 2026-09-09 |
| Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma Avelumab, Axitinib - Metastatic Adenoid Cystic Carcinoma, Progressive Disease | Phase 2 | Completed | M.D. Anderson Cancer Center | 40 | 2019-07-22 | 2024-10-18 |
Carcinoma, Adenoid Cystic (4) · Disease Progression (1) · Neoplasm Metastasis (1) · Recurrence (1) · Thyroid Cancer, Papillary (1)
Adenocarcinoma (4) · Carcinoma (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms, Glandular and Epithelial (4) · Disease Attributes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Adenocarcinoma, Papillary (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Head and Neck Neoplasms (1) · Neoplasms by Site (1) · Neoplastic Processes (1) · Thyroid Diseases (1)
Axitinib (1) · abemaciclib (1) · avelumab (1) · lenvatinib (1)
M.D. Anderson Cancer Center (1) · Michael J. Dennis, MD (1) · National Cancer Centre, Singapore (1) · Remix Therapeutics (1)
United States (3) · France (1) · Japan (1) · Malaysia (1) · Singapore (1) · South Korea (1)
Darren Wan-Teck Lim, MBBS (S'pore), MRCP (UK), FAMS (1) · Michael Dennis, MD (1) · Mythili Koneru, MD, PhD (1) · Renata Ferrarotto (1)